Metolazon Abcur (Metolazone)

Metolazone acts on the distal convoluted tubule of the kidney by blocking the Na+/Cl‑ cotransporter. This inhibition reduces reabsorption of sodium and chloride, leading to increased urinary excretion of water and electrolytes, which lowers extracellular fluid volume and systemic vascular resistance, thereby producing diuretic and antihypertensive effects.

The appropriate dose of Metolazon Abcur is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and renal function. Dosage may be adjusted over time, and patients should follow the prescriber’s instructions without self‑adjusting the amount.

Safety data for metolazone in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss risks with their healthcare provider.

To place an order, submit an enquiry on the Metolazon Abcur product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Metolazon Abcur (metolazone) is a thiazide‑like diuretic, often considered more potent than classic thiazides such as hydrochlorothiazide, especially in patients with reduced renal function. It provides effective diuresis at lower doses but shares a similar side‑effect profile, including electrolyte disturbances. Choice of agent depends on clinical context, renal function, and physician preference.

Metolazon Abcur should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Metolazon Abcur is taken orally, usually as a tablet, with a full glass of water. It may be taken with or without food, but consistent administration with respect to meals can help maintain stable absorption. Patients should follow the dosing schedule prescribed by their clinician.

The most serious risks include severe electrolyte abnormalities such as hypokalemia or hyponatremia, which can lead to cardiac arrhythmias, and acute renal impairment. Rare but serious reactions may involve allergic responses, pancreatitis, or blood dyscrasias. Prompt medical attention is required if any severe symptoms develop.

Metolazon Abcur is contraindicated in patients with anuria, severe hypersensitivity to metolazone or other sulfonamide drugs, and in those with severe hepatic impairment where fluid loss could be detrimental. Caution is also advised for individuals with uncontrolled diabetes, gout, or significant electrolyte disorders.